Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315471 · ClinicalTrials.gov registry record
Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis
A clinical trial of Takayasu's Arteritis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 224
- Enrollment target
- 9
- Study locations
NCT00315471 is a study of Takayasu's Arteritis that has completed, run by University of Pennsylvania. The registered enrollment target is 224 participants, below the 1,451-participant average among 4 other Takayasu's Arteritis trials with a reported enrollment target (85% lower). The trial reports 9 study locations across 6 states.
The verdict
NCT00315471, a study of Takayasu's Arteritis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 224 participants
- Enrollment target
- 9
- Study locations
Study Summary
Takayasu's arteritis is a rare disorder that causes swelling and damage to the large arteries in the body, such as the aorta. In order to ensure proper treatment, measuring disease activity is critical. The purpose of this study is to establish new biological markers (biomarkers) to assess the severity of disease in people with Takayasu's arteritis.
Conditions Studied
Study Locations (9)
Massachusetts
- Brigham and Women's Hospital - Boston
- Boston University School of Medicine - Boston
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh - Pittsburgh
Ontario
- St. Joseph's Healthcare - Hamilton
- Mount Sinai Hospital - Toronto
Minnesota
- Mayo Clinic College of Medicine - Rochester
Ohio
- Cleveland Clinic Foundation - Cleveland
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2006-04 |
| Est. Completion | 2019-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00315471
The ClinicalTrials.gov registry entry for NCT00315471 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,451-participant average among 4 other Takayasu's Arteritis trials with a reported enrollment target (85% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Takayasu's Arteritis appearing as the primary indexed condition, and to 0 interventions.
NCT00315471 reports 9 study locations spanning 6 distinct geographic areas - top geographies include Massachusetts, Pennsylvania, Ontario.
Frequently Asked Questions
What is clinical trial NCT00315471 about?
NCT00315471 is a clinical study titled "Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis". Takayasu's arteritis is a rare disorder that causes swelling and damage to the large arteries in the body, such as the aorta. In order to ensure proper treatment, measuring disease activity is critical. The purpose of this study is to establish new biological markers (biomarkers) to assess the sever...
What is the current status of trial NCT00315471?
This trial is currently completed. The enrollment target is 224 participants. The study started on 2006-04. Estimated completion is 2019-12.
What conditions does trial NCT00315471 study?
This clinical trial studies the following conditions: Takayasu's Arteritis.
Who is sponsoring clinical trial NCT00315471?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00315471 being conducted?
This trial has 9 study locations across Massachusetts, Minnesota, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Takayasu's Arteritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
One-Time DNA Study for Vasculitis
RECRUITING
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
RECRUITING
-
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
COMPLETED · Phase 2
-
Vasculitis Illness Perception (VIP) Study
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.